210 related articles for article (PubMed ID: 16612144)
1. Effect of c-Met expression on survival in head and neck squamous cell carcinoma.
Lo Muzio L; Farina A; Rubini C; Coccia E; Capogreco M; Colella G; Leonardi R; Campisi G; Carinci F
Tumour Biol; 2006; 27(3):115-21. PubMed ID: 16612144
[TBL] [Abstract][Full Text] [Related]
2. P-cadherin expression and survival rate in oral squamous cell carcinoma: an immunohistochemical study.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pannone G; Serpico R; Laino G; De Lillo A; Carinci F
BMC Cancer; 2005 Jun; 5():63. PubMed ID: 15967043
[TBL] [Abstract][Full Text] [Related]
3. Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma.
Lo Muzio L; Leonardi R; Mignogna MD; Pannone G; Rubini C; Pieramici T; Trevisiol L; Ferrari F; Serpico R; Testa N; De Rosa G; Staibano S
Anticancer Res; 2004; 24(2C):1063-9. PubMed ID: 15154624
[TBL] [Abstract][Full Text] [Related]
4. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
5. Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.
De Herdt MJ; Willems SM; van der Steen B; Noorlag R; Verhoef EI; van Leenders GJ; van Es RJ; KoljenoviÄ S; Baatenburg de Jong RJ; Looijenga LH
Oncotarget; 2016 Mar; 7(11):13167-81. PubMed ID: 26909606
[TBL] [Abstract][Full Text] [Related]
6. Effect of p63 expression on survival in oral squamous cell carcinoma.
Lo Muzio L; Campisi G; Farina A; Rubini C; Pastore L; Giannone N; Colella G; Leonardi R; Carinci F
Cancer Invest; 2007 Sep; 25(6):464-9. PubMed ID: 17882659
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of HSP27 in head and neck squamous cell carcinoma: a retrospective analysis of 57 tumours.
Lo Muzio L; Campisi G; Farina A; Rubini C; Ferrari F; Falaschini S; Leonardi R; Carinci F; Stalbano S; De Rosa G
Anticancer Res; 2006; 26(2B):1343-9. PubMed ID: 16619543
[TBL] [Abstract][Full Text] [Related]
8. P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.
Lo Muzio L; Pannone G; Mignogna MD; Staibano S; Mariggiò MA; Rubini C; Procaccini M; Dolci M; Bufo P; De Rosa G; Piattelli A
Histol Histopathol; 2004 Oct; 19(4):1089-99. PubMed ID: 15375751
[TBL] [Abstract][Full Text] [Related]
9. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
Kurihara-Shimomura M; Sasahira T; Nakamura H; Nakashima C; Kuniyasu H; Kirita T
J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
[TBL] [Abstract][Full Text] [Related]
10. FLOT-2 is an independent prognostic marker in oral squamous cell carcinoma.
Wen Q; Alnemah MM; Luo J; Wang W; Chu S; Chen L; Li J; Xu L; Li M; Zhou J; Fan S
Int J Clin Exp Pathol; 2015; 8(7):8236-43. PubMed ID: 26339392
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
12. HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.
Lo Muzio L; Leonardi R; Mariggiò MA; Mignogna MD; Rubini C; Vinella A; Pannone G; Giannetti L; Serpico R; Testa NF; De Rosa G; Staibano S
Histol Histopathol; 2004 Jan; 19(1):119-28. PubMed ID: 14702179
[TBL] [Abstract][Full Text] [Related]
13. High CDC20 expression is associated with poor prognosis in oral squamous cell carcinoma.
Moura IM; Delgado ML; Silva PM; Lopes CA; do Amaral JB; Monteiro LS; Bousbaa H
J Oral Pathol Med; 2014 Mar; 43(3):225-31. PubMed ID: 24044615
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA CEBPA-AS1 correlates with poor prognosis and promotes tumorigenesis via CEBPA/Bcl2 in oral squamous cell carcinoma.
Guo Y; Ma Y; Hu X; Song R; Zhu L; Zhong M
Cancer Biol Ther; 2018 Mar; 19(3):205-213. PubMed ID: 29281558
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the level of progression of extracapsular spread for cervical lymph node metastasis in oral squamous cell carcinoma.
Yamada S; Yanamoto S; Otani S; Hasegawa T; Miyakoshi M; Minamikawa T; Ohga N; Kamata T; Komori T; Kitagawa Y; Kurita H; Umeda M
Int J Oral Maxillofac Surg; 2016 Feb; 45(2):141-6. PubMed ID: 26439759
[TBL] [Abstract][Full Text] [Related]
16. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients.
Wang Y; Hu H; Wang Q; Li Z; Zhu Y; Zhang W; Wang Y; Jiang H; Cheng J
Pathol Res Pract; 2017 Aug; 213(8):969-974. PubMed ID: 28554766
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma.
Endo K; Shirai A; Furukawa M; Yoshizaki T
Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875
[TBL] [Abstract][Full Text] [Related]
18. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
19. Nuclear and cytoplasmic expression of Met in oral squamous cell carcinoma and in an organotypic oral cancer model.
Brusevold IJ; Søland TM; Khuu C; Christoffersen T; Bryne M
Eur J Oral Sci; 2010 Aug; 118(4):342-9. PubMed ID: 20662906
[TBL] [Abstract][Full Text] [Related]
20. Foxp3 overexpression in tumor cells predicts poor survival in oral squamous cell carcinoma.
Song JJ; Zhao SJ; Fang J; Ma D; Liu XQ; Chen XB; Wang Y; Cheng B; Wang Z
BMC Cancer; 2016 Jul; 16():530. PubMed ID: 27457382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
